Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article
Objective: To estimate the effects and safety of suprachoroidal triamcinolone acetonide injections in treating patients with resistant diabetic macular oedema. Methods: The quasi-experimental study was conducted at the Isra Postgraduate Institute of Ophthalmology, Al-Ibrahim Eye Hospital, Karachi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2023-01-01
|
| Series: | Journal of the Pakistan Medical Association |
| Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/2239 |
| _version_ | 1797820961689436160 |
|---|---|
| author | Asim Ateeq Saima Majid Nasir Ahmed Memon Nausheen Hayat Abdul Qadeem Somroo Abdul Fattah Memon |
| author_facet | Asim Ateeq Saima Majid Nasir Ahmed Memon Nausheen Hayat Abdul Qadeem Somroo Abdul Fattah Memon |
| author_sort | Asim Ateeq |
| collection | DOAJ |
| description |
Objective: To estimate the effects and safety of suprachoroidal triamcinolone acetonide injections in treating patients with resistant diabetic macular oedema.
Methods: The quasi-experimental study was conducted at the Isra Postgraduate Institute of Ophthalmology, Al-Ibrahim Eye Hospital, Karachi, from November 2019 to March 2020, and adult patients of either gender with uncontrolled diabetes mellitus. Central macular thickness, intraocular pressure and best corrected visual acuity were recorded at baseline, and the patients were followed up at one and three months after the suprachoroidal triamcinolone acetonide injection and post-intervention parameters were compared. Data was analysed using SPSS 20.
Results: There were 60 patients with a mean age of 49.25+/-5.6 years. Of the 70 eyes, 38(54.30%) belonged to male subjects and 32(45.70%) to female subjects. There were significant differences in terms of central macular thickness and the best corrected visual acuity at both follow-ups compared to the baseline readings (p<0.05).
Conclusion: Suprachoroidal triamcinolone acetonide injection significantly reduced diabetic macular oedema.
Key Words: Diabetic macular oedema, Intravitreal, Suprachoroidal, Triamcinolone.
|
| first_indexed | 2024-03-13T09:45:50Z |
| format | Article |
| id | doaj.art-b9f7636ffa0d493c92e6b0cbc0b59c7f |
| institution | Directory Open Access Journal |
| issn | 0030-9982 |
| language | English |
| last_indexed | 2024-03-13T09:45:50Z |
| publishDate | 2023-01-01 |
| publisher | Pakistan Medical Association |
| record_format | Article |
| series | Journal of the Pakistan Medical Association |
| spelling | doaj.art-b9f7636ffa0d493c92e6b0cbc0b59c7f2023-05-25T04:21:06ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822023-01-0173210.47391/JPMA.2239Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original articleAsim Ateeq0Saima Majid1Nasir Ahmed Memon2Nausheen Hayat3Abdul Qadeem Somroo4Abdul Fattah Memon5Department of Ophthalmology, Isra Postgraduate Institute of Ophthalmology, Karachi, PakistanDepartment of Ophthalmology, Isra Postgraduate Institute of Ophthalmology, Karachi, PakistanDepartment of Ophthalmology, Isra Postgraduate Institute of Ophthalmology, Karachi, PakistanDepartment of Ophthalmology, Jinnah Postgraduate Medical Centre, Karachi, PakistanDepartment of Ophthalmology, Isra Postgraduate Institute of Ophthalmology, Karachi, PakistanDepartment of Ophthalmology, Isra Postgraduate Institute Of Ophthalmology, Karachi, Pakistan Objective: To estimate the effects and safety of suprachoroidal triamcinolone acetonide injections in treating patients with resistant diabetic macular oedema. Methods: The quasi-experimental study was conducted at the Isra Postgraduate Institute of Ophthalmology, Al-Ibrahim Eye Hospital, Karachi, from November 2019 to March 2020, and adult patients of either gender with uncontrolled diabetes mellitus. Central macular thickness, intraocular pressure and best corrected visual acuity were recorded at baseline, and the patients were followed up at one and three months after the suprachoroidal triamcinolone acetonide injection and post-intervention parameters were compared. Data was analysed using SPSS 20. Results: There were 60 patients with a mean age of 49.25+/-5.6 years. Of the 70 eyes, 38(54.30%) belonged to male subjects and 32(45.70%) to female subjects. There were significant differences in terms of central macular thickness and the best corrected visual acuity at both follow-ups compared to the baseline readings (p<0.05). Conclusion: Suprachoroidal triamcinolone acetonide injection significantly reduced diabetic macular oedema. Key Words: Diabetic macular oedema, Intravitreal, Suprachoroidal, Triamcinolone. https://www.ojs.jpma.org.pk/index.php/public_html/article/view/2239 |
| spellingShingle | Asim Ateeq Saima Majid Nasir Ahmed Memon Nausheen Hayat Abdul Qadeem Somroo Abdul Fattah Memon Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article Journal of the Pakistan Medical Association |
| title | Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article |
| title_full | Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article |
| title_fullStr | Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article |
| title_full_unstemmed | Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article |
| title_short | Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema (SCTA): original article |
| title_sort | suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular edema scta original article |
| url | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/2239 |
| work_keys_str_mv | AT asimateeq suprachoroidalinjectionoftriamcinoloneacetonideformanagementofresistantdiabeticmacularedemasctaoriginalarticle AT saimamajid suprachoroidalinjectionoftriamcinoloneacetonideformanagementofresistantdiabeticmacularedemasctaoriginalarticle AT nasirahmedmemon suprachoroidalinjectionoftriamcinoloneacetonideformanagementofresistantdiabeticmacularedemasctaoriginalarticle AT nausheenhayat suprachoroidalinjectionoftriamcinoloneacetonideformanagementofresistantdiabeticmacularedemasctaoriginalarticle AT abdulqadeemsomroo suprachoroidalinjectionoftriamcinoloneacetonideformanagementofresistantdiabeticmacularedemasctaoriginalarticle AT abdulfattahmemon suprachoroidalinjectionoftriamcinoloneacetonideformanagementofresistantdiabeticmacularedemasctaoriginalarticle |